髂动脉与股浅动脉支架术治疗间歇性跛行的远期结局及主要肢体不良事件
基于VQI外周血管介入登记数据,纳入2010至2022年首次孤立性髂动脉支架(2250例)或股浅动脉支架(1374例)治疗的跛行患者。髂动脉支架组1年免于主要肢体不良事件(MALE)的比例为94%,股浅动脉支架组为83%(P<0.001),股浅动脉支架与MALE最强相关(HR 2.96,95%CI 2.16-4.04)。长期随访两组跛行症状缓解比例无差异(P=0.469)。
要点
- 髂动脉支架组1年免于MALE比例94%,股浅动脉支架组83%,差异主要源于再干预。
- 多变量Cox回归显示股浅动脉支架与MALE最强相关(HR 2.96,95%CI 2.16-4.04)。
- 长期随访两组跛行症状缓解比例无差异(P=0.469)。
核心结论
- 与髂动脉支架相比,股浅动脉支架治疗的跛行患者围手术期并发症和1年MALE发生率更高,但长期症状缓解无差异。
研究设计与样本
- 利用Vascular Quality Initiative(VQI)外周血管介入登记数据,识别2010至2022年因跛行首次接受孤立性髂动脉或股浅动脉支架的患者,排除慢性肢体威胁性缺血、急性肢体缺血或既往干预者,主要终点为MALE(包括通畅性丧失、大截肢和靶血管再干预),采用Kaplan-Meier分析和Cox回归建模。
主要发现
- 共2250例接受髂动脉支架,1374例接受股浅动脉支架。
- 术中髂动脉支架组透视时间17.1 vs. 股浅动脉支架组21.7分钟(P<0.001),造影剂用量118 vs. 125 mL(P=0.003),夹层发生率8.6% vs. 3.0%(P<0.001)。
- 1年免于MALE比例髂动脉支架组94% vs. 股浅动脉支架组83%(P<0.001),差异主要源于再干预。
- 多变量Cox回归显示股浅动脉支架与MALE最强相关(HR 2.96,95%CI 2.16-4.04,P<0.001)。
- 长期随访两组跛行症状缓解比例无差异(P=0.469)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Iliac artery and superficial femoral artery (SFA) stenting are common procedures to relieve claudication. We investigate major adverse limb events (MALE), follow-up symptoms and perioperative complications between the 2 interventions. METHODS: Utilizing the Vascular Quality Initiative (VQI) Peripheral Vascular Intervention registry, we identified patients undergoing a first-time, isolated iliac artery or SFA stenting for claudication from 2010 to 2022. Patients with chronic limb threatening limb ischemia, acute limb ischemia, or prior interventions were excluded. Our primary end point was MALE, comprised of patency loss, major amputation, and target vessel reintervention. Outcomes were analyzed with Kaplan-Meier analysis and Cox regression modeling. RESULTS: A total of 2,250 patients underwent iliac artery stenting; 1,374 patients underwent SFA stenting. Intraoperatively, iliac artery stenting demonstrated decreased fluoroscopy time (17.1 vs. 21.7 min, P < 0.001), decreased contrast usage (118 vs. 125 mL, P = 0.003), and lower rates of dissection (8.6% vs. 3.0%, P < 0.001). Ninety-four percent of claudicants with iliac stenting were free from MALE at 1-year, compared to 83% of claudicants with SFA stenting (P < 0.001), predominantly due to reinterventions. On multivariable Cox regression analysis, SFA stenting was most strongly associated with MALE (hazard ratio: 2.96 [95% confidence interval: 2.16, 4.04], P < 0.001). On long-term follow-up, there was no difference in the proportion of patients with claudication symptom resolution (P = 0.469). CONCLUSION: Claudicants undergoing SFA interventions have higher rates of perioperative complications and 1-year MALE compared to iliac artery interventions, despite no differences in long-term symptom resolution.
引用
- Shi R, Sundaram S, Tanious A, et al. Long-Term Outcomes and Major Adverse Limb Events in Claudicants Undergoing Iliac Artery Stenting versus Superficial Femoral Artery Stenting. Ann Vasc Surg. 2025. PMID: 40349829. doi:10.1016/j.avsg.2025.04.135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。